Non-Invasive Preeclampsia Screening and Biobank
NCT06643741
This study is recruiting at 16 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Preeclampsia (PE)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- Sequenom, Inc.
- Last updated on ClinicalTrials.gov
- July 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Valley Perinatal · Glendale, AZ
Delaware · 1
- Delaware Center for Maternal and Fetal Medicine · Newark, DE
Louisiana · 1
- Southern Clinical Research Associates · Metairie, LA
New Jersey · 3
- New Jersey Perinatal Associates · Livingston, NJ
- Rutgers Robert Wood Johnson Medical School · New Brunswick, NJ
- Capital Health · Pennington, NJ
New York · 2
- Columbia University Medical Center · New York, NY
- Lenox Hill Hospital · New York, NY
North Carolina · 1
- Wake Forest University Health Sciences · Winston-Salem, NC
Pennsylvania · 1
- University of Pennsylvania Perelman School of Medicine · Philadelphia, PA
Tennessee · 1
- Chattanooga Medical Research · Chattanooga, TN
Texas · 4
- St. David's Women's Center of Texas · Austin, TX
- University of Texas Medical Branch · Galveston, TX
- HCA Healthcare, Texas Maternal Fetal Medicine · Houston, TX
- UT Health · Houston, TX
Virginia · 1
- Macon & Joan Brock Virginia Health Sciences at Old Dominion University · Norfolk, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.